Price
Target price
€258.60
€258.60
-2.380%
-6.3
-2.380%
€297.60
18:31 / Tradegate
WKN: 864330 / Symbol: WST / Name: West Pharmaceutical Services / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
West Pharmaceutical Services Inc. Stock
We can see a decrease in the price for West Pharmaceutical Services Inc.. Compared to yesterday it has lost -€6.300 (-2.380%).
With 14 Buy predictions and not the single Sell prediction the community is currently very high on West Pharmaceutical Services Inc..
As a result the target price of 297 € shows a slightly positive potential of 14.85% compared to the current price of 258.6 € for West Pharmaceutical Services Inc..
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | -2.380% | 15.677% | 27.356% | 37.682% | 13.060% | -20.450% | -0.935% |
| Bio-Rad Labs Inc. A | -6.450% | -2.591% | 5.388% | 9.463% | -6.708% | -42.550% | -54.604% |
| CONMED Corp. | 0.630% | 0.621% | 4.516% | -23.585% | -7.429% | -68.846% | -70.545% |
| Integra LifeSciences Holdings Corp | 0.000% | -1.093% | 13.125% | -36.268% | -14.623% | -82.925% | -85.285% |
Comments
West Pharmaceutical Services (WST) had its "buy" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (WST) had its "outperform" rating reaffirmed by Evercore Inc.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for WST provided by MarketBeat